ConductScience.org, home

Paper39458124

Treatment Strategies' Impact on Progression-Free Survival According to RMST Function in Metastatic Colorectal Cancer Patients: A Retrospective Study from Romania.

Pirvu EE and 7 others. J Clin Med, 2024. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Treatment Strategies' Impact on Progression-Free Survival According to RMST Function in Metastatic Colorectal Cancer Patients: A Retrospective Study from Romania. Papers, record 39458124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39458124

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment Strategies' Impact on Progression-Free Survival According to RMST Function in Metastatic Colorectal Cancer Patients: A Retrospective Study from Romania.
PubMed
Journal
J Clin Med
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0.0, provisional
iCite
Revised in PubMed
2024-10-28
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pirvu EEEdvina Elena
2Severin EEmiliahttps://orcid.org/0000-0003-3901-615X
3Patru RIRaluca Ileana
4Nita IIrina
5Toma SAStefania Andreea
6Croitoru BEBianca Elena
7Munoz Groza AEAdriana Estefa
8Marinescu GGabriela

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125844824Factors Associated With Guideline-recommended KRAS Testing in Colorectal Cancer Patients: A Population-based Study.Am J Clin Oncol2017https://conductscience.org/library/papers/25844824PubMed
219124802KRAS mutations and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: practical application of patient selection.J Clin Oncol2009https://conductscience.org/library/papers/19124802PubMed
332140476Surgical approach to synchronous colorectal liver metastases: staged, combined, or reverse strategy.Hepatobiliary Surg Nutr2020https://conductscience.org/library/papers/32140476PubMed
420856756Chemotherapy treatments for metastatic colorectal cancer: is evidence-based medicine in practice?J Oncol Pract2008https://conductscience.org/library/papers/20856756PubMed
515166961Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.Ann Surg2004https://conductscience.org/library/papers/15166961PubMed
626818619Global patterns and trends in colorectal cancer incidence and mortality.Gut2017https://conductscience.org/library/papers/26818619PubMed
735003738
Inoperable de novo metastatic colorectal cancer with primary tumour in situ: Evaluating discordant responses to upfront systemic therapy of the primary tumours and metastatic sites and complications arising from primary tumours (experiences from an Irish Cancer Centre).
Mol Clin Oncol2022https://conductscience.org/library/papers/35003738PubMed
819022550The effect of socioeconomic status on survival from colorectal cancer in the Melbourne Collaborative Cohort Study.Soc Sci Med2009https://conductscience.org/library/papers/19022550PubMed
937761297
Correlations between Demographic, Clinical, and Paraclinical Variables and Outcomes in Patients with KRAS-Mutant or KRAS Wild-Type Metastatic Colorectal Cancer-A Retrospective Study from a Tertiary-Level Center in Romania.
Diagnostics (Basel)2023https://conductscience.org/library/papers/37761297PubMed
1037285096Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer.Ann Surg Oncol2023https://conductscience.org/library/papers/37285096PubMed
1119679400Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer.Pathol Res Pract2009https://conductscience.org/library/papers/19679400PubMed
1234716838Management of Colorectal Cancer with Synchronous Liver Metastases: An Inception Cohort Study (CoSMIC).Ann Surg Oncol2022https://conductscience.org/library/papers/34716838PubMed
1334663410Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies.J Exp Clin Cancer Res2021https://conductscience.org/library/papers/34663410PubMed
1418316791Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.J Clin Oncol2008https://conductscience.org/library/papers/18316791PubMed
1531972237Precision Therapy in RAS Mutant Colorectal Cancer.Gastroenterology2020https://conductscience.org/library/papers/31972237PubMed
1623177514Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.Lancet2013https://conductscience.org/library/papers/23177514PubMed
1733538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed
1821611958The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt.Stat Med2011https://conductscience.org/library/papers/21611958PubMed
1910493478Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.Ann Surg1999https://conductscience.org/library/papers/10493478PubMed
2022696357Radiofrequency ablation in the treatment of liver metastases from colorectal cancer.Cochrane Database Syst Rev2012https://conductscience.org/library/papers/22696357PubMed

See all 33 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
KRAS3845PubTator's text mininghttps://conductscience.org/library/genes/3845

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39458124

GET https://conductscience.org/api/papers/v1/39458124/references?page=2